Diasome Pharmaceuticals

About:

Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.

Website: https://www.diasome.com/

Twitter/X: diasome

Top Investors: Medicxi, JDRF T1D Fund, Quaker BioVentures, McDonald Partners, Devon Park BioVentures

Description:

Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes. Diasome Pharmaceuticals was founded in 2004 and is based in Conshohocken, Pennsylvania.